Pursuant to Regulations 30 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, Eiko Lifesciences has enclosed a copy of newspaper publication in the following newspapers dated 27th May, 2026 with respect to Audited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Year ended 31st March, 2026 approved at the meeting of Board of Directors held on Tuesday, 26th May, 2026: 1. Mumbai Lakshadeep (Marathi), 2. Financial Express (English). Copy of the results are also uploaded on the website of the Company - www.eikolifesciences.com.
The above information is a part of company’s filings submitted to BSE.